Medicines Marketed by Glaxosmithkline Pharmaceuticals Ltd

About GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited is a renowned pharmaceutical and healthcare company that has been operating in India since 1924. Initially established under the name H.J.Foster & Co. Limited, the company later evolved into its current identity.

With its headquarters in Mumbai, Maharashtra, GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of the global biopharma company GSK plc, which has a presence in over 75 countries worldwide.

The company specialises in the development, manufacture, and distribution of a wide range of prescription medicines and vaccines. The company's comprehensive product portfolio and global reach make it a significant player in addressing diverse health needs across different markets.

GlaxoSmithKline Pharmaceuticals Limited Products

GlaxoSmithKline Pharmaceuticals Limited offers a comprehensive range of pharmaceutical products, including prescription medicines and vaccines. The company's prescription medicines cover a broad spectrum of therapeutic areas, such as anti-infectives for treating bacterial, viral, and fungal infections; and dermatological treatments for skin-related conditions.

The company also produces products in other areas, such as gynaecological medicines for women's health and reproductive health; diabetes treatments and management options; oncology therapies for cancer; cardiovascular medicines for heart and blood vessel conditions; and respiratory treatments for lung and breathing disorders.

In addition to prescription medicines, GlaxoSmithKline Pharmaceuticals Limited is well-known for its extensive vaccine portfolio. The company manufactures vaccines for the prevention of various diseases, including hepatitis A and B, invasive disease caused by H. influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, and cervical cancer. GlaxoSmithKline Pharmaceuticals Limited's strong focus on research and development enables the company to produce innovative and effective treatments and vaccines. The company is committed to making its products affordable and accessible through responsible pricing and strategic access programmes, aligning with global health and sustainability goals.